| Ytd | 57.26% | |
| 1y | -43.35% |
| Open | 0.96 | Prev Close | 0.98 | Low | 0.96 | High | 1.02 | Mkt Cap | 48.46M |
| Vol | 426.12K | Avg Vol | 6.78M | EPS | -0.73 | P/E | N/A | Forward P/E | -0.86 |
| Beta | 0.41 | Short Ratio | 2.09 | Inst. Own | 72.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-30 | 50-d Avg | 0.82 | 200-d Avg | 0.66 | 1yr Est | 12.00 |
Werewolf Therapeutics (HOWL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing o
LITE, HOWL, PERI, GSBD and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 9th
Shares of Werewolf Therapeutics, Inc. (NASDAQ: HOWL - Get Free Report) have been assigned an average
BALA CYNWYD, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the follow
Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Sept. 9, 202
BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the follow
BALA CYNWYD, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Werewolf Therapeutics,
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - HOWL, HZO, T
Werewolf Therapeutics (HOWL) stock exploded higher on Friday morning after management said the compa
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's
Dow gains 400 points, Materials sector up 2.3%, Werewolf Therapeutics up 113%, S&P PMI rises to
US stocks rise, Dow gains over 350 points as markets open Friday; Materials sector up 2%, utilitie
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) was one of the market's biggest pre-market movers on Frida
Werewolf Therapeutics surged after announcing a $500 million merger with Ambros Therapeutics, puttin
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday
WALTHAM, Mass. and SAN DIEGO, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq:
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI,
Werewolf Therapeutics shares surge 89.94% after hours as $33 million deal with EMD Serono brings fre
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday&#
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly earnings of $0.08 per share which beat the an
WATERTOWN, Mass., July 31, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “W
Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular
Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expect
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.28) per share which met the ana
WATERTOWN, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “We
Company continues to evaluate strategic options to maximize shareholder value Company continues to e
WATERTOWN, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the
Shares of Werewolf Therapeutics, Inc. (NASDAQ: HOWL - Get Free Report) have earned a consensus recom
Werewolf Therapeutics, Inc. (NASDAQ: HOWL - Get Free Report) Director Luke Evnin sold 24,678 shares
Werewolf Therapeutics, Inc. (NASDAQ: HOWL - Get Free Report) Director Luke Evnin sold 24,962 shares
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that i
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company an
Wednesday saw 219 companies set new 52-week lows.
Tuesday's session saw 167 companies set new 52-week lows.